TITLE

Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-- study protocol

AUTHOR(S)
Diem, Ricarda; Molnar, Fanni; Beisse, Flemming; Gross, Nikolai; Drüschler, Katharina; Heinrich, Sven P.; Joachimsen, Lutz; Rauer, Sebastian; Pielen, Amelie; Sühs, Kurt-Wolfram; Linker, Ralf Andreas; Huchzermeyer, Cord; Albrecht, Philipp; Hassenstein, Andrea; Aktas, Orhan; Guthoff, Tanja; Tonagel, Felix; Kernstock, Christoph; Hartmann, Kathrin; Kümpfel, Tania
PUB. DATE
March 2016
SOURCE
BMJ Open;2016, Vol. 6 Issue 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
113834785

 

Related Articles

  • Erythropoietin for Optic Neuritis: Improvements in Structure, but Will Function Follow? Dinkin, Marc // Neurology Alert;Oct2012, Vol. 31 Issue 2, p14 

    THE PROGNOSIS FOR VISUAL RECOVERY IN PATIENTS WITH A first episode of optic neuritis is good, with > 95% of patients recovering to better than 20/40 visual acuity at 1 year, with or without treatment with IV methylprednisolone. Yet, the remaining 5% of patients may be left with severe visual...

  • Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin. Sühs, Kurt-Wolfram; Papanagiotou, Panagiotis; Hein, Katharina; Pul, Refik; Scholz, Kerstin; Heesen, Christoph; Diem, Ricarda // International Journal of Molecular Sciences;Oct2016, Vol. 17 Issue 10, p1 

    Changes in cerebral lesion load by magnetic resonance imaging (MRI) in patients from a double-blind, placebo-controlled, phase II study on erythropoietin in clinically isolated optic neuritis (ClinicalTrials.gov, NCT00355095) were analyzed. Therefore, patients with acute optic neuritis were...

  • Research progresses in optic neuritis trial. Beck, Roy W. // Ophthalmology Times;12/1/96, Vol. 21 Issue 29, p6 

    Discusses the developments in the treatment of optic neuritis focusing on the results of the Optic Neuritis Treatment Trial (ONTT). Guidelines for the treatment of optic neuritis; Funding for the study; Eligibility criteria for ONTT.

  • Results even in neuritis trial. Kuznar, Wayne // Ophthalmology Times;2/6/95, Vol. 20 Issue 6, p12 

    Presents information from the Optic Neuritis Treatment Trial (ONTT) on optic neuritis patients given corticosteroid treatments for six months. Experimental methodology; Rates of recovery; Serologic studies on patients; Remarks on study confirmation. INSET: At a glance..

  • Five group comparisons of treatments for anxiety disorders. Sharp, D. M.; Power, K. G.; Simpson, R. J. // British Journal of Psychiatry;Dec95, Vol. 167, p820 

    A letter to the editor is presented in response to the article "Paroxetine in the treatment of panic disorder: A randomised, double-blind placebo-controlled study," by S. Oehrberg and colleagues.

  • Lithium Not Effective for Lou Gehrig's Disease. Gaby, Alan R. // Townsend Letter;Aug/Sep2010, Issue 325/326, p26 

    A review of the article "Safety and Efficacy of Lithium in Combination With Riluzole for Treatment of Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial" published in the periodical "Lancet Neurology" in 2010 is presented.

  • Local IRBs, Multicenter Trials, and the Ethics of Internal Amendments. Jansen, Lynn A. // IRB: Ethics & Human Research;Jul/Aug2005, Vol. 27 Issue 4, p7 

    Discusses a case study presented before a local institutional review board to review a protocol for a randomized, double-blind, placebo-controlled trial for the treatment of schizophrenia. Criteria for the eligibility of individuals to participate in the study; Evaluation of responses to...

  • THE EFFECT OF VITAMIN AND MINERAL SUPPLEMENTS ON INFECTIONS AND COGNITIVE FUNCTION IN OLDER PEOPLE: A RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.  // Age & Ageing;Nov2005 Supplement 2, Vol. 34, pii12 

    This paper presents the abstract of the study "The effect of vitamin and mineral supplements on infections and cognitive function in older people: A randomised double-blind, placebo-controlled trial," by D. G. Seymour.

  • Brain MRI useful for predicting risk of MS in optic neuritis. Groves, Nancy // Ophthalmology Times;3/15/2008, Vol. 33 Issue 9, p20 

    The article focuses on the use of brain magnetic resonance imaging (MRI) for predicting the risks of multiple sclerosis development in patients with optic neuritis. It discusses the Optic Neuritis Treatment Trial and the Longitudinal Optic Neuritis Study, and mentions their findings regarding...

  • Gabapentin - the 'Holy Grail' for chronic cough suffers?  // PharmacoEconomics & Outcomes News;9/15/2012, Issue 662, p10 

    The article discusses the results of a placebo-controlled study which shows that gabapentin treatment resulted in improvements in the cough-specific quality of life (QOL) of patients with refractory chronic cough. It references the research "Gabapentin for refractory chronic cough: A randomised,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics